ÂÜÀòÂÒÂ×

Holly Bilton is an accomplished professional in the field of nuclear medicine, currently serving as an Ambassador for the Oncidium Foundation, where efforts focus on improving access to cancer treatments and clinical trials. In addition, Holly holds the role of Executive Chair at the Canadian Medical Isotope Ecosystem Development Fund, promoting collaborations to enhance medical isotope supply and technologies. Holly's extensive experience at the Centre for Probe Development and Commercialization includes positions as Associate Director of Business Development, Associate Director of Research & Project Management, and Research Manager, all centered on advancing radiopharmaceutical programs toward clinical application. Holly Bilton earned a Doctor of Philosophy in Chemical Biology from McMaster University and a Bachelor of Science in Chemistry from Wilfrid Laurier University.